Age Impairs Soluble Guanylyl Cyclase Function in Mouse Mesenteric Arteries

被引:12
作者
Zhong, Cheng [1 ,2 ,3 ]
Xu, Minze [1 ,2 ,3 ]
Boral, Senguel [2 ,3 ,4 ]
Summer, Holger [5 ]
Lichtenberger, Falk-Bach [1 ,2 ,3 ]
Erdogan, Cem [1 ,2 ,3 ]
Gollasch, Maik [6 ,7 ]
Golz, Stefan [5 ]
Persson, Pontus B. [1 ,2 ,3 ]
Schleifenbaum, Johanna [1 ,2 ,3 ]
Patzak, Andreas [1 ,2 ,3 ]
Khedkar, Pratik H. [1 ,2 ,3 ]
机构
[1] Charite Univ Med Berlin, Inst Vegetat Physiol, Charitepl 1, D-10117 Berlin, Germany
[2] Free Univ Berlin, Charitepl 1, D-10117 Berlin, Germany
[3] Humboldt Univ, Charitepl 1, D-10117 Berlin, Germany
[4] Charite Univ Med Berlin, Inst Pathol, Charitepl 1, D-10117 Berlin, Germany
[5] Bayer AG, Res & Dev, D-42113 Wuppertal, Germany
[6] Charite Univ Med Berlin, Expt & Clin Res Ctr ECRC, D-13125 Berlin, Germany
[7] Univ Greifswald, Dept Internal & Geriatr Med, Geriatr Med, D-17475 Greifswald, Germany
关键词
aging; mesenteric artery; nitric oxide; soluble guanylyl cyclase; soluble guanylyl cyclase activator; NITRIC-OXIDE SYNTHASE; PHOSPHODIESTERASE 3A EXPRESSION; BLOOD-PRESSURE; ENDOTHELIAL DYSFUNCTION; CORONARY-ARTERY; HYPERTENSION; VASODILATION; STRESS; VASCULATURE; ACTIVATION;
D O I
10.3390/ijms222111412
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Endothelial dysfunction (ED) comes with age, even without overt vessel damage such as that which occurs in atherosclerosis and diabetic vasculopathy. We hypothesized that aging would affect the downstream signalling of the endothelial nitric oxide (NO) system in the vascular smooth muscle (VSM). With this in mind, resistance mesenteric arteries were isolated from 13-week (juvenile) and 40-week-old (aged) mice and tested under isometric conditions using wire myography. Acetylcholine (ACh)-induced relaxation was reduced in aged as compared to juvenile vessels. Pretreatment with L-NAME, which inhibits nitrix oxide synthases (NOS), decreased ACh-mediated vasorelaxation, whereby differences in vasorelaxation between groups disappeared. Endothelium-independent vasorelaxation by the NO donor sodium nitroprusside (SNP) was similar in both groups; however, SNP bolus application (10(-6) mol L-1) as well as soluble guanylyl cyclase (sGC) activation by runcaciguat (10(-6) mol L-1) caused faster responses in juvenile vessels. This was accompanied by higher cGMP concentrations and a stronger response to the PDE5 inhibitor sildenafil in juvenile vessels. Mesenteric arteries and aortas did not reveal apparent histological differences between groups (van Gieson staining). The mRNA expression of the alpha 1 and alpha 2 subunits of sGC was lower in aged animals, as was PDE5 mRNA expression. In conclusion, vasorelaxation is compromised at an early age in mice even in the absence of histopathological alterations. Vascular smooth muscle sGC is a key element in aged vessel dysfunction.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] The deactivation of soluble guanylyl cyclase by redox-active agents
    Dierks, EA
    Burstyn, JN
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1998, 351 (01) : 1 - 7
  • [42] Distribution of soluble guanylyl cyclase in rat retina
    Ding, Jin-Dong
    Weinberg, Richard J.
    JOURNAL OF COMPARATIVE NEUROLOGY, 2007, 500 (04) : 734 - 745
  • [43] Distribution of soluble guanylyl cyclase in the rat brain
    Ding, JD
    Burette, A
    Nedvetsky, PI
    Schmidt, HHHW
    Weinberg, RJ
    JOURNAL OF COMPARATIVE NEUROLOGY, 2004, 472 (04) : 437 - 448
  • [44] Differential mechanisms for insulin-induced relaxations in mouse posterior tibial arteries and main mesenteric arteries
    Qu, Dan
    Liu, Jian
    Lau, Chi Wai
    Huang, Yu
    VASCULAR PHARMACOLOGY, 2014, 63 (03) : 173 - 177
  • [45] The effect of hypercholesterolemia on platelet soluble guanylyl cyclase
    Kottenberg-Assenmacher, E
    Weber, M
    Kojda, G
    VASCULAR PHARMACOLOGY, 2003, 40 (03) : 141 - 147
  • [46] Guanylyl cyclase structure, function and regulation
    Potter, Lincoln R.
    CELLULAR SIGNALLING, 2011, 23 (12) : 1921 - 1926
  • [47] Acute blood pressure effects of YC-1-induced activation of soluble guanylyl cyclase in normotensive and hypertensive rats
    Rothermund, L
    Friebe, A
    Paul, M
    Koesling, D
    Kreutz, R
    BRITISH JOURNAL OF PHARMACOLOGY, 2000, 130 (02) : 205 - 208
  • [48] RNA splicing in regulation of nitric oxide receptor soluble guanylyl cyclase
    Sharina, Iraida G.
    Cote, Gilbert J.
    Martin, Emil
    Doursout, Marie-Francoise
    Murad, Ferid
    NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2011, 25 (03): : 265 - 274
  • [49] Cloning and functional expression of the rat α2 subunit of soluble guanylyl cyclase
    Koglin, M
    Behrends, S
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 2000, 1494 (03): : 286 - 289
  • [50] Soluble guanylyl cyclase stimulators and activators: Promising drugs for the treatment of hypertension?
    Gawrys, Olga
    Kala, Petr
    Sadowski, Janusz
    Melenovsky, Vojtech
    Sandner, Peter
    Cervenka, Ludek
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2025, 987